Please login to the form below

Not currently logged in
Email:
Password:

Merck KGaA shakes up pharma leadership

Stefan Oschmann becomes deputy CEO as Belén Garijo assumes more responsibility

merck stefan oschmannMerck KGaA has made several changes to the leadership of its pharmaceutical business.

At the start of next year Stefan Oschmann (top right), current CEO for pharma, will move to a new role as deputy CEO of the entire group. He will also become vice chairman of the executive board.

Oschmann will be replaced by Belén Garijo (bottom right), current CEO of Merck's biotech division Merck Serono in a move that will expand her responsibilities, adding oversight for consumer health, allergy and biosimilars.

Johannes Baillou, chairman of the board of partners of Merck, said: “With today's management decisions we strengthen Merck's leadership team and prepare the ground for continuity to reach our ambitious growth targets until the year 2018 and beyond.”

Belén Garijo, Merck KGaAThe announced comes one year after Garijo left her role as Merck Serono's chief operating officer to replace Oschmann as CEO of the division.

Garijo's career prior to joining Merck in 2011 included a spell at Sanofi, where she led global integrations of the company's acquisition of Genzyme.

Oschmann also joined Merck in 2011, having spent the previous 11 years at its US-based namesake Merck & Co, known as MSD outside the US and Canada.

19th September 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics